Overexpression of A1, an NF-κB-inducible anti-apoptotic BCL gene, inhibits endothelial cell activation

Blood

Volumn 93, Issue 11, 1999, Pages 3803-3810

  Stroka, Deborah M ^a   Badrichani, Anne Z ^a   Bach, Fritz H ^a   Ferran, Christiane ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL ACTIVATION; HEMOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 0033153009     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.11.3803     Document Type: Article

References (56)

1. Cotran RS, Pober JS: Endothelial activation and inflammation. Prog Immunol 8:747, 1989
2. Gimbrone MAJ: Vascular endothelium: An integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol 75:67, 1995
3. Pober JS, Doukas J, Hughes CC, Savage CO, Munro JM, Cotran RS: The potential roles of vascular endothelium in immune reactions. Human Immunol 28:258, 1990
4. Ferran C, Peuchmaur M, Desruennes M, Ghoussoub JJ, Cabrol A, Brousse N, Cabrol C, Bach JF, Chatenoud L: Implications of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejection. Transplantation 55:605, 1993
5. Blakely ML, van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW: Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059, 1994
6. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 50:537, 1990
7. Ward PA: Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils. Am J Med 91:89S, 1991
8. Wang JH, Redmond HP, Watson RWG, Duggan S, McCarthy J, Barry M, Bouchier-Hayes D: Mechanisms involved in the induction of human endothelial cell necrosis. Cell Immunol 168:91, 1996
9. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB: Induction of endothelial cell apoptosis by TNF-α: Modulation by inhibitors of protein synthesis. Exp Cell Res 214:584, 1994
10. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
11. Boise LH, Gonzalez GM, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-xL, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
12. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ: Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 182:821, 1995
13. Karsan A, Yee E, Harlan JM: Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member A1. J Biol Chem 271:27201, 1996
14. Lu QL, Poulsom R, Wong L, Hanby AM: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431, 1993
15. Karsan A, Yee E, Kaushansky K, Harlan JM: Cloning of a human Bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87:3089, 1996
16. Opipari AJ, Boguski MS, Dixit VM: The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 265:14705, 1990
17. Opipari AJ, Hu HM, Yabkowitz R, Dixit VM: The A20 zinc finger protein protects cells from TNF cytotoxicity. J Biol Chem 267:12424, 1992
18. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J: Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J Exp Med 188:211, 1998
19. Lin EY, Orlofsky A, Berger MS, Prystowsky MB: Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979, 1993
20. Choi SS, Park IC, Yun JW, Sung YC, Hong SI, Shin HS: A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11:1693, 1995
21. Read MA, Whitley MZ, Williams AJ, Collins T: NF-κB and IκBα - An inducible regulatory system in endothelial activation. J Exp Med 179:503, 1994
22. Ferran C, Millan MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH, Winkler H: Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun 214:212, 1995
23. Baeuerle PA, Baltimore D: IκB: A specific inhibitor of the NF-κB transcription factor. Science 242:540, 1988
24. Gimbrone MJ, Cotran RS, Folkman J: Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60:673, 1974
25. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C: A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 271:18068, 1996
26. Zimmermann K, Dobrovnik M, Ballaun C, Bevec D, Hauber J, Böhnlein E: Transactivation of the HIV-1 LTR by the HIV-Tat and HTLV-1 Tax proteins is mediated by different cis-acting sequences. Virology 182:874, 1991
27. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, de Martin R: Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J Exp Med 183:1013, 1996
28. Bevilacqua MP, Stengelin S, Gimbrone MA, Seed B: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243: 1160, 1989
29. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Bach FH: Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: A means of evaluating the role of EC activation in xenograft rejection. Transplant Proc 29:879, 1997
30. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138:447, 1991
31. Hu X, Yee E, Harlan JM, Wong F, Karsan A: Lipopolysaccharide induces the antiapoptotic molecules A1 and A20, in microvascular endothelial cells. Blood 92:2759, 1998
32. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 84:9238, 1987
33. Brostjan C, Anrather J, Csizmadia V, Natarajan G, Bach FH, Winkler H: Deletion analysis of the porcine E-selectin promoter. Transplant Proc 28:649, 1996
34. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H: Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBa synthesis. J Biol Chem 271:19612, 1996
35. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H: Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J Clin Invest 99:763, 1997
36. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D: Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev 6:775, 1992
37. Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma IM: Tumor necrosis factor α-induced phosphorylation of IκB-α is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 91:12740, 1994
38. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Benneriah Y: Stimulation-dependent IκB-α phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitinproteasome pathway. Proc Natl Acad Sci USA 92:10599, 1995
39. Mellits KH, Hay RT, Goodbourn S: Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res 21:5059, 1993
40. Traenckner EB, Wilk S, Bauerle P: A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylation form of IκBα that is still bound to NF-κB. EMBO J 13:5433, 1994
41. Grimm S, Bauer MKA, Bauerle PA, Schultze-Osthoff K: Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol 134:13, 1996
42. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB, Korsmeyer SJ: Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 92:7834, 1995
43. Fernandez-Sarabia M, Bischoff JR: Bcl-2 associates with the ras-related protein R-ras p23. Nature 366:274, 1993
44. Chen CY, Faller DV: Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J Biol Chem 271:2376, 1996
45. Wang HG, Miyashita T, Takayama S, Sato T, Torigoe T, Krajewski S, Tanaka S, Hovey Lr, Troppmair J, Rapp UR, Reed JC: Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 9:2751, 1994
46. Wang HG, Rapp UR, Reed JC: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629, 1996
47. Shibasaki F, Kondo E, Akagi T, McKeon F: Suppression of signalling through transcription factor NF-AT interactions between calcineurin and Bcl-2. Nature 386:728, 1997
48. Krikos A, Laherty CD, Dixit VM: Transcriptional activation of the TNFα-inducible zinc finger protein, A20, is mediated by κB elements. J Biol Chem 267:17971, 1992
49. Laherty CD, Perkins ND, Dixit VM: Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J Biol Chem 268:5032, 1993
50. Bach FH, Hancock WW, Ferran C: Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 18:483, 1997
51. Wrighton CJ, McShea A, de Martin R, Ferran C, Bach FH: Prevention of NF-κB activation in TNFα-stimulated porcine aortic endothelial cells by constitutive expression of IκBα renders cells sensitive to TNF-induced programmed cell death. III International Congress of Transplantation A91, 1995 (abstr)
52. Wang C-Y, Mayo MW, Baldwin ASJ: TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784, 1996
53. VanAntwerp D, Martin S, Jafri T, Green D, Verma I: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787, 1996
54. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782, 1996
55. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, Soares M, Grey ST, Bach FH: A20 inhibits NF-κB activation in endothelial cells without sensitizing to TNF-mediated apoptosis. Blood 91:2249, 1998
56. L serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J Clin Invest 103:543, 1999